BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32890740)

  • 21. Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis.
    Bontempo S; Yeganeh L; Giri R; Vincent AJ
    Climacteric; 2024 Feb; 27(1):93-103. PubMed ID: 37933495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Menopausal hormone therapy and breast cancer.
    Santen RJ
    J Steroid Biochem Mol Biol; 2014 Jul; 142():52-61. PubMed ID: 23871991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of menopausal hormone therapy: recalibrating the balance of benefit and risk.
    Rajan S; Kreatsoulas C
    Pol Arch Intern Med; 2019 Apr; 129(4):276-280. PubMed ID: 30608056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asthma and the menopause: a systematic review and meta-analysis.
    Zemp E; Schikowski T; Dratva J; Schindler C; Probst-Hensch N
    Maturitas; 2012 Nov; 73(3):212-7. PubMed ID: 22964072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Precision hormone therapy: identification of positive responders.
    Kim YJ; Brinton RD
    Climacteric; 2021 Aug; 24(4):350-358. PubMed ID: 33615942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.
    Khalil RA
    Biochem Pharmacol; 2013 Dec; 86(12):1627-42. PubMed ID: 24099797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive health after menopause: Does menopausal hormone therapy affect it?
    Stute P; Wienges J; Koller AS; Giese C; Wesemüller W; Janka H; Baumgartner S
    Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101565. PubMed ID: 34538724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Menopausal hormone therapy use and breast cancer risk in Australia: Findings from the New South Wales Cancer, Lifestyle and Evaluation of Risk study.
    Salagame U; Banks E; Sitas F; Canfell K
    Int J Cancer; 2016 Apr; 138(8):1905-14. PubMed ID: 26599391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effects of Menopause Hormone Therapy on Lipid Profile in Postmenopausal Women: A Systematic Review and Meta-Analysis.
    Nie G; Yang X; Wang Y; Liang W; Li X; Luo Q; Yang H; Liu J; Wang J; Guo Q; Yu Q; Liang X
    Front Pharmacol; 2022; 13():850815. PubMed ID: 35496275
    [No Abstract]   [Full Text] [Related]  

  • 32. Menopausal hormone therapy and risk of lung cancer-Systematic review and meta-analysis.
    Greiser CM; Greiser EM; Dören M
    Maturitas; 2010 Mar; 65(3):198-204. PubMed ID: 20031346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
    Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
    J Clin Oncol; 2009 Nov; 27(31):5138-43. PubMed ID: 19752341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menopausal hormone therapy and gallbladder disease: the Study of Health in Pomerania (SHIP).
    Schwarz S; Völzke H; Baumeister SE; Hampe J; Dören M
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):51-9. PubMed ID: 17437513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of BMI and hormone therapy in melanoma risk: a case-control study.
    De Giorgi V; Gori A; Savarese I; D'Errico A; Scarfì F; Papi F; Maio V; Covarelli P; Massi D; Gandini S
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1191-1197. PubMed ID: 28289899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular Risk/Benefit Profile of MHT.
    Villa P; Amar ID; Shachor M; Cipolla C; Ingravalle F; Scambia G
    Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31500138
    [No Abstract]   [Full Text] [Related]  

  • 37. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition.
    Bakken K; Fournier A; Lund E; Waaseth M; Dumeaux V; Clavel-Chapelon F; Fabre A; Hémon B; Rinaldi S; Chajes V; Slimani N; Allen NE; Reeves GK; Bingham S; Khaw KT; Olsen A; Tjønneland A; Rodriguez L; Sánchez MJ; Etxezarreta PA; Ardanaz E; Tormo MJ; Peeters PH; van Gils CH; Steffen A; Schulz M; Chang-Claude J; Kaaks R; Tumino R; Gallo V; Norat T; Riboli E; Panico S; Masala G; González CA; Berrino F
    Int J Cancer; 2011 Jan; 128(1):144-56. PubMed ID: 20232395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association with menopausal hormone therapy and asymptomatic gallstones in US women in the third National Health and Nutrition Examination Study.
    Jackson SS; Graubard BI; Gabbi C; Koshiol J
    Sci Rep; 2024 Jan; 14(1):191. PubMed ID: 38168135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Menopausal hormonal therapy and breast cancer.].
    Bakhidze EV; Belyaeva AV; Berlev IV; Anisimov VN; Belyaev AM
    Adv Gerontol; 2021; 34(2):277-286. PubMed ID: 34245512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menopausal hormone therapy and biliary tract cancer: a population-based matched cohort study in Sweden.
    Kilander C; Lagergren J; Konings P; Sadr-Azodi O; Brusselaers N
    Acta Oncol; 2019 Mar; 58(3):290-295. PubMed ID: 30656997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.